Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Indian billionaire Mittal considering lifting stake in BT - report

(Sharecast News) - Indian billionaire Sunil Bharti Mittal has reportedly indicated that he is considering increasing his holding in BT Group after taking a 24.5% stake in the telecoms firm last year. The Financial Times cited people familiar with the matter as saying that Mittal, who bought the BT stake from Patrick Drahi's Altice in August last year, has privately suggested that he could expand his position in the company - held via his Bharti Enterprises conglomerate - as it continues to restructure and cut costs under chief executive Allison Kirkby.

It was understood that Mittal is in the process of converting his 24.5% stake, which was partly taken via derivatives contracts, into equity.

Mittal took an initial 10% holding last year, which is being increased to 24.5% after securing national security approvals in December.

The FT said New Street Research analyst James Ratzer estimates that Mittal has converted about 16% of his stake in total into equity. Sources said that Mittal would not look to increase his BT holding until that process was finished.

A spokesperson for Bharti told the FT the company "currently has no plans to buy any further stake above the 24.5%".

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.